Method of manufacture of 1,3-oxathiolane nucleosides

Details for Australian Patent Application No. 2008201983 (hide)

Owner Gilead Sciences, Inc. Emory University

Inventors Soria, Jose; Sznaidman, Marcos Luis; Painter, George R.; Cleary, Darryl; Liotta, Dennis C.; Almond, Merrick

Agent Davies Collison Cave

Pub. Number AU-B-2008201983

Parent 2004202930

Filing date 5 May 2008

Wipo publication date 29 May 2008

Acceptance publication date 15 March 2012

International Classifications

C07D 327/04 (2006.01) Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms

A61K 31/505 (2006.01) - Pyrimidines

C07D 319/06 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 411/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

22 May 2008 Complete Application Filed

29 May 2008 Application Open to Public Inspection

  Published as AU-B-2008201983

15 March 2012 Application Accepted

  Published as AU-B-2008201983

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201984-Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)- 1,3-oxathiolane

2008201982-Combination of a Knife Storage Block and a Knife Sharpener